Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants
Status:
Completed
Trial end date:
2012-10-25
Target enrollment:
Participant gender:
Summary
The purpose of this study was to investigate the effects of QTI571 (imatinib) on
pharmacokinetics of bosentan and sildenafil at steady state when co-administered to
participants with pulmonary arterial hypertension.